Prokidney (PROK) Cash from Investing Activities (2021 - 2026)

Prokidney (PROK) reported Cash from Investing Activities of $34.8 million for Q1 2026, up 23.11% year-over-year from $28.3 million in Q1 2025, and up 23.97% quarter-over-quarter from $28.1 million in Q4 2025.

Prokidney (PROK) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Cash from Investing Activities data on file, last reported at $34.8 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $34.8 million, up 23.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.5 million (up 1239.68% YoY), and the FY2025 annual result was $104.0 million, up 409.28% from the prior year.
  • Cash from Investing Activities advanced to $34.8 million in Q1 2026 per PROK's latest filing, from $28.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $58.4 million in Q1 2024 and troughed at -$192.6 million in Q1 2023.
  • A 5-year average of -$10.1 million and a median of -$207000.0 in 2022 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities slumped 31221.57% in 2023, then jumped 317.21% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$306000.0 in 2022, then tumbled by 31221.57% to -$95.8 million in 2023, then surged by 115.73% to $15.1 million in 2024, then soared by 86.29% to $28.1 million in 2025, then grew by 23.97% to $34.8 million in 2026.
  • Business Quant data shows PROK's Cash from Investing Activities at $34.8 million in Q1 2026, $28.1 million in Q4 2025, and $29.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Prokidney 259.01 Mn 1.55 Bn - 34.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.83 Mn
Mar 31, 2026 34.83 Mn
Dec 31, 2025 28.09 Mn
Dec 31, 2025 28.09 Mn
Sep 30, 2025 29.02 Mn
Sep 30, 2025 29.02 Mn
Jun 30, 2025 18.57 Mn
Jun 30, 2025 18.57 Mn
Mar 31, 2025 28.29 Mn
Mar 31, 2025 28.29 Mn
Dec 31, 2024 15.08 Mn
Dec 31, 2024 15.08 Mn
Sep 30, 2024 -81.64 Mn
Sep 30, 2024 -81.64 Mn
Jun 30, 2024 28.57 Mn
Jun 30, 2024 28.57 Mn
Mar 31, 2024 58.40 Mn
Mar 31, 2024 58.40 Mn
Dec 31, 2023 -95.84 Mn
Dec 31, 2023 -95.84 Mn